Healthcare

By

Martin Tillier

 | Feb 11, 2014 | 1:30 PM EST

Unwarranted pessimism has driven the shares down.

By

Jim Cramer

 | Feb 11, 2014 | 12:59 PM EST

I like living, breathing examples of growth stocks going right.

By

David Katz

 | Feb 7, 2014 | 10:35 AM EST

They should improve shareholder value in coming months.

By

Carolyn Boroden

 | Jan 26, 2014 | 5:00 PM EST

Here's what we'd need to see before trying a reentry.

By

Roger Arnold

 | Jan 21, 2014 | 6:00 PM EST

What that means for investors and policymakers alike.

By

Jim Cramer

 | Jan 17, 2014 | 11:07 AM EST

This biotech comes with high hopes and question marks.

By

Carolyn Boroden

 | Jan 17, 2014 | 7:00 AM EST

Regeron's technicals -- and the current pullback -- all add up to a buy.

By

Herb Greenberg

 | Jan 15, 2014 | 9:00 AM EST

This rollup name is on the stock-market equivalent of steroids.

By

Charles Gabriel

 | Jan 14, 2014 | 5:30 PM EST

Any remedies for managed-care companies and Medicaid HMOs?

By

Sham Gad

 | Jan 13, 2014 | 3:00 PM EST

Kindred Biosciences is a unique player in an underserved market.

There were nice reversal-type candles on the weekly charts of the major indices. The DOW a...
A number of stocks on my watch lists are attempting to form positive candles a key suppor...
While last week was a day to pull the plug and contemplate where the market was headed, I ...
Shares of TSLA have formed multiple hammer candles at a key level of support defined by: t...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.